Allelic loss and microsatellite instability in prostate cancers in Japan

Oncology

Volumn 55, Issue 6, 1998, Pages 569-574

  Watanabe, Masatoshi ^a   Shiraishi, Taizo ^a   Muneyuki, Tsuyoshi ^a   Nagai, Moritaka ^a   Fukutome, Kazuo ^a   Murata, Mariko ^a   Kawamura, Jyuichi ^a   Yatani, Ryuichi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Heterozygosity, loss; Microsatellite instability; Prostate cancer

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 8P; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; JAPAN; MALE; MICROSATELLITE INSTABILITY; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0031723681     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011914     Document Type: Article

References (35)

1. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
2. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancer. Science 1990;247:49-56.
3. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359:235-237.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
5. Wooster R, Bingell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792.
6. Bergerheim USR, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosome 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 1991;3:215-220.
7. Kunimi K, Bergerheim USR, Larsson I-L, Ekman P, Collins VP: Allelotyping of human prostatic adenocarcinoma, Genomics 1991;11: 530-536.
8. Komiya A, Suzuki H, Ueda T, Yatani R, Emi M, Ito H, Shimazaki J: Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 1996;17:245-253.
9. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J: Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 1996;17:225-233.
10. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin J-P, Järvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A: Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816.
11. Han H-J, Yanagisawa A, Kato Y, Park J-G, Nakamura Y: Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993;53:5087-5089.
12. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
13. Gleason DF, Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 1974;111:58-64.
14. Japanese Urological Association and the Japanese Pathological Society: General Rules for Clinical and Pathological Studies on Prostatic Cancer, ed 2. Tokyo, Kanahara, 1992.
15. Watanabe M, Imai H, Shiraishi T, Shimazaki J, Kotake T, Yatani R: Microsatellite instability in human prostate cancer. Br J Cancer 1995; 72:562-564.
16. Breukel C, Tops C, van Leeuwen C, van der Klift H, Nakamura Y, Fodde R, Khan PM: CA repeat polymorphism at the D5S82 locus, proximal to adenomatous polyposis coli (APC). Nucleic Acids Res 1991;19:5804.
17. Crundwell MC, Chughtai S, Knowles M, Takle L, Luscombe M, Neoptolemos JP, Morton DG, Phillips SMA: Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer. Int J Cancer 1996;69:295-300.
18. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV: Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002-1005.
19. Gudmundsson J, Johannesdottir G, Bergthorsson JT, Arason A, Ingvarsson S, Egilsson V, Barkardottir RB: Different tumor types from BRCA2 carriers show wild-type chromosome deletion on 13q12-q13. Cancer Res 1995;55: 4830-4832.
20. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weisenbach J: The 1993-94 Genethon human genetic linkage map. Nat Genet 1994;7:246-339.
21. Jones MH, Nakamura Y: Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 1992;5:89-90.
22. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ: Evidence for three suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 1995;55:5390-5395.
23. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB: Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 1995;55:4114-4119.
24. Bova GS, Isaacs WB: Review of allelic loss and gain in prostate cancer. World J Urol 1996;14: 338-346.
25. Brewster SF, Browne S, Brown KW: Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic cancer. J Urol 1994;151:1073-1077.
26. Watanabe M, Kakiuchi H, Kato H, Shiraishi T, Yatani R, Sugimura T, Nagao M: APC gene mutations in human prostate cancer. Jpn J Clin Oncol 1996;26:77-81.
27. Konishi N, Enomoto T, Buzard G, Ohshima M, Ward JM, Rice JM: K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 1992;69:2293-2299.
28. Watanabe M, Shiraishi T, Yatani R, Nomura AMY, Stemmermann GN: International comparison on ras gene mutations in latent prostate carcinoma. Int J Cancer 1994;58:174-178.
29. Watanabe M, Fukutome K, Shiraishi T, Murata M, Kawamura J, Shimazaki J, Kotake T, Yatani R: Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries. Carcinogenesis 1997;18:1355-1358.
30. Suzuki H, Komiya A, Aida S, Akimoto S, Shiraishi T, Yatani R, Igarashi T, Shimazaki T: Microsatellite instability and other molecular abnormalities in human prostate cancer. Jpn J Cancer Res 1995;86:956-961.
31. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ: Frequent loss of expression and loss of heterozygosity of the putative tumor suppression gene DCC in prostatic carcinoma. Cancer Res 1993;53:2723-2727.
32. Arason A, Barkardottir RB, Egilsson V: Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostate cancer. Am J Hum Genet 1993;52:711-717.
33. Li J, Yen C, Liaw K, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275: 1943-1947.
34. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-362.
35. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 1990;50:5863-5867.